Morgan Stanley Raises Cigna Corporation (NYSE:CI) Price Target to $188.00

Cigna Corporation (NYSE:CI) had its price objective increased by Morgan Stanley from $184.00 to $188.00 in a report released on Monday, August 7th. They currently have an overweight rating on the health services provider’s stock.

A number of other equities research analysts have also recently commented on the company. Jefferies Group LLC restated a buy rating and set a $178.00 target price (up from $172.00) on shares of Cigna Corporation in a research report on Sunday, April 23rd. Zacks Investment Research upgraded Cigna Corporation from a hold rating to a buy rating and set a $175.00 target price on the stock in a research report on Tuesday, April 25th. Stifel Nicolaus raised their target price on Cigna Corporation from $170.00 to $175.00 and gave the company a buy rating in a research report on Friday, May 5th. Deutsche Bank AG raised their target price on Cigna Corporation from $172.00 to $175.00 and gave the company a buy rating in a research report on Wednesday, May 10th. Finally, Royal Bank Of Canada raised their target price on Cigna Corporation from $172.00 to $177.00 and gave the company an outperform rating in a research report on Monday, May 15th. Three research analysts have rated the stock with a hold rating, seventeen have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. The stock has a consensus rating of Buy and an average price target of $180.44.

Shares of Cigna Corporation (CI) traded down 0.56% on Monday, reaching $177.03. The company’s stock had a trading volume of 1,034,361 shares. Cigna Corporation has a one year low of $115.03 and a one year high of $181.00. The firm has a 50-day moving average price of $173.66 and a 200 day moving average price of $160.28. The firm has a market capitalization of $44.57 billion, a PE ratio of 20.43 and a beta of 0.46.

Cigna Corporation (NYSE:CI) last posted its earnings results on Friday, August 4th. The health services provider reported $2.91 EPS for the quarter, beating the Zacks’ consensus estimate of $2.48 by $0.43. Cigna Corporation had a return on equity of 17.40% and a net margin of 5.55%. The firm had revenue of $10.32 billion for the quarter, compared to analysts’ expectations of $10.26 billion. During the same period last year, the firm earned $1.98 EPS. The company’s quarterly revenue was up 3.6% on a year-over-year basis. On average, analysts anticipate that Cigna Corporation will post $10.03 earnings per share for the current fiscal year.

ILLEGAL ACTIVITY NOTICE: This piece was first posted by Community Financial News and is the property of of Community Financial News. If you are accessing this piece on another website, it was illegally stolen and republished in violation of international trademark & copyright laws. The legal version of this piece can be viewed at https://www.com-unik.info/2017/08/19/cigna-corporation-nyseci-pt-raised-to-188-00-updated.html.

In other Cigna Corporation news, EVP Lisa R. Bacus sold 11,455 shares of the business’s stock in a transaction on Wednesday, May 24th. The shares were sold at an average price of $161.57, for a total value of $1,850,784.35. Following the completion of the transaction, the executive vice president now owns 24,753 shares in the company, valued at $3,999,342.21. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, insider Michael W. Triplett sold 1,439 shares of the business’s stock in a transaction on Wednesday, June 14th. The stock was sold at an average price of $166.89, for a total transaction of $240,154.71. Following the completion of the transaction, the insider now owns 26,199 shares of the company’s stock, valued at approximately $4,372,351.11. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 243,463 shares of company stock worth $41,678,984. Corporate insiders own 1.30% of the company’s stock.

Institutional investors have recently bought and sold shares of the company. Capstone Investment Advisors Netherlands B.V. acquired a new position in Cigna Corporation during the second quarter valued at approximately $106,000. American Beacon Advisors Inc. acquired a new position in Cigna Corporation during the first quarter valued at approximately $102,000. Baystate Wealth Management LLC increased its position in Cigna Corporation by 436.1% in the first quarter. Baystate Wealth Management LLC now owns 772 shares of the health services provider’s stock valued at $116,000 after buying an additional 628 shares during the period. Founders Capital Management acquired a new position in Cigna Corporation during the first quarter valued at approximately $117,000. Finally, Parallel Advisors LLC increased its position in Cigna Corporation by 62.3% in the second quarter. Parallel Advisors LLC now owns 800 shares of the health services provider’s stock valued at $139,000 after buying an additional 307 shares during the period. Institutional investors and hedge funds own 87.61% of the company’s stock.

Cigna Corporation Company Profile

Cigna Corporation (Cigna), together with its subsidiaries, is a health services company. The Company offers medical, dental, disability, life and accident insurance and related products and services. The Company’s segments include Global Health Care, Global Supplemental Benefits, Group Disability and Life, and Other Operations and Corporate.

Analyst Recommendations for Cigna Corporation (NYSE:CI)

What are top analysts saying about Cigna Corporation? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Cigna Corporation and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit